The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798
- PMID: 2274546
The in vivo electrophysiological actions of the new potassium channel blockers, tedisamil and UK 68,798
Similar articles
-
Actions of cardiac drugs on a calcium-dependent potassium channel in hippocampal neurons.Mol Pharmacol. 1991 Apr;39(4):540-6. Mol Pharmacol. 1991. PMID: 2017153
-
Further studies into the ECG effects of tedisamil (KC 8857) in rats.Proc West Pharmacol Soc. 1989;32:183. Proc West Pharmacol Soc. 1989. PMID: 2780585 No abstract available.
-
Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.J Pharmacol Exp Ther. 1990 Aug;254(2):560-9. J Pharmacol Exp Ther. 1990. PMID: 2384886
-
Antiarrhythmic drug therapy of atrial fibrillation: focus on new agents.J Cardiovasc Pharmacol Ther. 2003 Jun;8 Suppl 1:S27-31. doi: 10.1177/107424840300800104. J Cardiovasc Pharmacol Ther. 2003. PMID: 12746749 Review.
-
Clinical differences between the newer antiarrhythmic agents.Europace. 2000 Jul;1 Suppl C:C16-22. Europace. 2000. PMID: 11220520 Review.
Cited by
-
Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.Br J Pharmacol. 1996 Mar;117(6):1261-9. doi: 10.1111/j.1476-5381.1996.tb16724.x. Br J Pharmacol. 1996. PMID: 8882624 Free PMC article.
-
Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.Br J Pharmacol. 1991 Jan;102(1):13-8. doi: 10.1111/j.1476-5381.1991.tb12124.x. Br J Pharmacol. 1991. PMID: 2043919 Free PMC article.